Editorial: Cannabis is not as benign as we too often tend to believe

✦ New
CED Clinical Relevance
#72 Notable Clinical Interest
Emerging findings or policy developments worth monitoring closely.
SafetyMental HealthResearchPolicy
Why This Matters
Clinicians need to counsel patients that cannabis impairs driving ability despite users’ subjective perception of safety, as epidemiological data demonstrates increased accident risk that contradicts user confidence levels. This gap between perceived and actual impairment has direct implications for patient counseling, workplace safety assessments, and clinical risk evaluation when cannabis use is disclosed. Understanding this bias is essential for providers to effectively communicate cannabis-related harms and inform patients about realistic functional limitations.
Clinical Summary

This editorial highlights a critical safety concern regarding cannabis use and impaired driving, noting that users systematically overestimate their driving ability while under the influence despite objective accident data demonstrating significant impairment risk. The disconnect between subjective perception and actual performance capacity presents a clinical counseling challenge, as patients may underestimate cannabis-related impairment similar to alcohol intoxication. This evidence suggests cannabis carries greater risks than commonly perceived by both users and some clinicians, warranting more cautious clinical messaging about activity restrictions following use. The findings have direct implications for patient safety conversations, particularly for working-age adults and those in safety-sensitive occupations who may rationalize cannabis use as lower risk than other substances. Clinicians should counsel patients that cannabis impairs driving ability despite subjective feelings of competence, and advise against operating vehicles or machinery after use, similar to alcohol guidance. When discussing cannabis with patients, practitioners should move beyond assumptions of benignity and explicitly address driving safety and impairment risks as part of a comprehensive risk assessment.

Dr. Caplan’s Take
“After two decades of prescribing cannabis, I’ve learned that the subjective feeling of impairment bears almost no relationship to actual cognitive and motor deficits, and patients need to hear this clearly: if you use cannabis and drive, you’re making a decision that affects not just your safety but everyone on the road with you.”
Clinical Perspective

๐Ÿ’Š While cannabis is increasingly perceived as a low-risk substance, evidence suggests this perception diverges meaningfully from actual harm, particularly regarding impaired driving. The disconnect between subjective impairment and objective driving performance is clinically important because patients may underestimate risk and make unsafe decisions about operating vehicles after use. Healthcare providers should recognize that cannabis impairs judgment in ways that may be less subjectively noticeable than alcohol, potentially creating a false sense of safety that contributes to accident risk. When counseling patients about cannabis use, clinicians should explicitly discuss driving safety and the unreliability of self-assessment of impairment, particularly given the variable cannabinoid content in modern products and individual differences in tolerance. Framing cannabis as carrying genuine, if sometimes less obvious, safety risks during clinical discussions may help align patient perception with epidemiological reality and support safer decision-making.

💬 Join the Conversation

Have a question about how this applies to your situation? Ask Dr. Caplan →

Want to discuss this topic with other patients and caregivers? Join the forum discussion →